Works matching IS 03407004 AND DT 2018 AND VI 67 AND IP 10

Results: 15

Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1635, doi. 10.1007/s00262-018-2233-x

By:

Chen, Ting;
Li, Qing;
Wu, Jiao;
Wu, Yaxin;
Peng, Wei;
Li, Huan;
Wang, Jianmei;
Tang, Xiaowei;
Peng, Yan;
Fu, Xiangsheng

Publication type:

Article

Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1647, doi. 10.1007/s00262-018-2223-z

By:

Albertini, Mark R.;
Yang, Richard K.;
Ranheim, Erik A.;
Hank, Jacquelyn A.;
Zuleger, Cindy L.;
Weber, Sharon;
Neuman, Heather;
Hartig, Greg;
Weigel, Tracey;
Mahvi, David;
Henry, Mary Beth;
Quale, Renae;
McFarland, Thomas;
Gan, Jacek;
Carmichael, Lakeesha;
Kim, KyungMann;
Loibner, Hans;
Gillies, Stephen D.;
Sondel, Paul M.

Publication type:

Article

Regulatory mechanisms of PD-L1 expression in cancer cells.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1481, doi. 10.1007/s00262-018-2226-9

By:

Shi, Yongyu

Publication type:

Article

Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1-CH3 fusion protein.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1621, doi. 10.1007/s00262-018-2221-1

By:

Pan, Zeyan;
Di, Shengmeng;
Shi, Bizhi;
Jiang, Hua;
Shi, Zhimin;
Liu, Ying;
Wang, Yi;
Luo, Hong;
Yu, Min;
Wu, Xiuqi;
Li, Zonghai

Publication type:

Article

Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1589, doi. 10.1007/s00262-018-2220-2

By:

Morales-Molina, Álvaro;
Gambera, Stefano;
Cejalvo, Teresa;
Moreno, Rafael;
Rodríguez-Milla, Miguel Ángel;
Perisé-Barrios, Ana Judith;
García-Castro, Javier

Publication type:

Article

Older melanoma patients aged 75 and above retain responsiveness to anti-PD1 therapy: results of a retrospective single-institution cohort study.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1571, doi. 10.1007/s00262-018-2219-8

By:

Ibrahim, Tony;
Mateus, Christine;
Baz, Maria;
Robert, Caroline

Publication type:

Article

Epidermal growth factor receptor peptide vaccination induces cross-reactive immunity to human EGFR, HER2, and HER3.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1559, doi. 10.1007/s00262-018-2218-9

By:

Doyle, Hester A.;
Koski, Raymond A.;
Bonafé, Nathalie;
Bruck, Ross A.;
Tagliatela, Stephanie M.;
Gee, Renelle J.;
Mamula, Mark J.

Publication type:

Article

Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine.

Published in:

2018

By:

Shima, Hiroaki;
Kutomi, Goro;
Satomi, Fukino;
Imamura, Masafumi;
Kimura, Yasutoshi;
Mizuguchi, Toru;
Watanabe, Kazue;
Takahashi, Akari;
Murai, Aiko;
Tsukahara, Tomohide;
Kanaseki, Takayuki;
Hirohashi, Yoshihiko;
Iwayama, Yuji;
Tsuruma, Tetsuhiro;
Kameshima, Hidekazu;
Sato, Noriyuki;
Torigoe, Toshihiko;
Takemasa, Ichiro

Publication type:

Case Study

3-Day monocyte-derived dendritic cells stimulated with a combination of OK432, TLR7/8 ligand, and prostaglandin E<sub>2</sub> are a promising alternative for cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1611, doi. 10.1007/s00262-018-2216-y

By:

Yi, Dag Heiro;
Stetter, Nadine;
Jakobsen, Kjerstin;
Jonsson, Roland;
Appel, Silke

Publication type:

Article

High-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with T<sub>reg</sub> depletion.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1545, doi. 10.1007/s00262-018-2214-0

By:

Löhr, Mario;
Freitag, Benjamin;
Technau, Antje;
Krauss, Jürgen;
Monoranu, Camelia-Maria;
Rachor, Johannes;
Lutz, Manfred B.;
Hagemann, Carsten;
Kessler, Almuth F.;
Linsenmann, Thomas;
Wölfl, Matthias;
Ernestus, Ralf-Ingo;
Engelhardt, Sabrina;
Gelbrich, Götz;
Schlegel, Paul G.;
Eyrich, Matthias

Publication type:

Article

Cytotoxic activity of effector T cells against cholangiocarcinoma is enhanced by self-differentiated monocyte-derived dendritic cells.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1579, doi. 10.1007/s00262-018-2212-2

By:

Panya, Aussara;
Thepmalee, Chutamas;
Sawasdee, Nunghathai;
Sujjitjoon, Jatuporn;
Phanthaphol, Nattaporn;
Junking, Mutita;
Wongkham, Sopit;
Yenchitsomanus, Pa-thai

Publication type:

Article

Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1519, doi. 10.1007/s00262-018-2211-3

By:

Owens, Gemma L.;
Price, Marcus J.;
Cheadle, Eleanor J.;
Hawkins, Robert E.;
Gilham, David E.;
Edmondson, Richard J.

Publication type:

Article

Safety and immunogenicity of a potential checkpoint blockade vaccine for canine melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1533, doi. 10.1007/s00262-018-2201-5

By:

Kurupati, Raj K.;
Zhou, Xiangyang;
Xiang, Zhiquan;
Keller, Lorraine H.;
Ertl, Hildegund C. J.

Publication type:

Article

A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1505, doi. 10.1007/s00262-018-2198-9

By:

van de Loosdrecht, Arjan A.;
van Wetering, Sandra;
Santegoets, Saskia J. A. M.;
Singh, Satwinder Kaur;
Eeltink, Corien M.;
den Hartog, Yvonne;
Koppes, Malika;
Kaspers, Jorn;
Ossenkoppele, Gert J.;
Kruisbeek, Ada M.;
de Gruijl, Tanja D.

Publication type:

Article

Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1491, doi. 10.1007/s00262-018-2184-2

By:

Barberi, Theresa;
Martin, Allison;
Suresh, Rahul;
Barakat, David J.;
Harris-Bookman, Sarah;
Drake, Charles G.;
Lim, Michael;
Friedman, Alan D.

Publication type:

Article